DICE Therapeutics OverviewDICE Therapeutics Other Income Expense Net
Other Income/Expense Net for DICE.
Quarterly Other Income/Expense
$4.68M
↑ 2008.56% YoY
As of Jun 30, 2023
Annual Other Income/Expense (TTM)
$14.46M
↑ 2296.81% YoY
Trailing 12 months ending Jun 30, 2023